logo-loader
viewValley Fever Solutions

Valley Fever Solutions looking forward to beginning Phase II trials to treat Valley Fever

Valley Fever Solutions, Inc. President and CEO David Larwood spoke to Proactive at theBiotech Showcase 2020 in San Francisco. The privately-held, Arizona-based company is developing a potential cure for Valley Fever. According to its website, the company anticipates starting a pivotal trial in Q4 2020.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

5 minutes ago

2 min read